Press Release IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 7 hours ago
Press Release IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers Jul 27